Background: The relationship between resilience, one of the important issues in mental health, and therapeutic regimen compliance, the key in the successful management of chronic disease such as chronic kidney disease, is unclear. 
Objective: The aim of this study was to determine the relationship between resilience and therapeutic regimen compliance in ESRD patients, undergoing hemodialysis.
Methods: In this cross-sectional study, 107 hemodialysis patients referred to Besat and Shahid Beheshti Hospitals of Hamedan, Iran were selected through systematic sampling method from January to April 2013. The tool was Connor-Davidson Resilience Scale (CD-RISC). The criteria for compliance were: mean of interdialytic weight gain less than 5.7% to the dry weight, serum potassium 5.5 mEq/L or less, serum phosphorus of 6 mg/dL or less and no more than 3 absences in dialysis sessions. For data analysis, statistical tests such as independent t-test and Logistic regression were performed.
Results: Fifty-seven (53.3%) patients were males and the mean age of subjects was 49.96±17.39 years. The difference in the mean scores of resilience between compliance or non-compliance patients was statistically significant (p=0.032). Only resilience and age were significant factors related to regimen compliance. In those subjects with greater resilience for 1 score, the chance of compliance with the therapeutic regimen would be 5.4% higher (OR=1.054, CI 95%: 1.01-1.103). In addition, the elderly patients were more likely to comply with the regimen (OR=1.072, CI 95 %: 1.033, 1.113).
Conclusion: According to the results, the patients with greater scores of resilience were more likely to comply with the therapeutic regimen.


Keywords: Hemodialysis, Resilience, Patient compliance


» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/6853
adidasAir Jordan 1

The  most recent editorial (June 2021)

Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?

An editorial by Dr. Mehrdad Jalalian

Read more.

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.


To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


Our previous editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: